You have access
Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia
C. J. Schmidt, D. S. Chapin, J. Cianfrogna, M. L. Corman, M. Hajos, J. F. Harms, W. E. Hoffman, L. A. Lebel, S. A. McCarthy, F. R. Nelson, C. Proulx-LaFrance, M. J. Majchrzak, A. D. Ramirez, K. Schmidt, P. A. Seymour, J. A. Siuciak, F. D. Tingley, R. D. Williams, P. R. Verhoest and F. S. Menniti
Journal of Pharmacology and Experimental Therapeutics May 2008, 325 (2) 681-690; DOI: https://doi.org/10.1124/jpet.107.132910